Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,279 | -8,242 | -6,794 | -5,038 | -2,121 |
| Depreciation Amortization | 6 | 164 | 157 | 107 | 32 |
| Accounts receivable | 1 | -179 | -3 | -94 | -31 |
| Accounts payable and accrued liabilities | -62 | -607 | -242 | -86 | 33 |
| Other Working Capital | 550 | 141 | 547 | 812 | 423 |
| Other Operating Activity | 179 | 2,624 | 1,994 | 1,352 | 331 |
| Operating Cash Flow | $-1,604 | $-6,098 | $-4,340 | $-2,947 | $-1,332 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -28 | -28 | -23 | -15 |
| Investing Cash Flow | $-18 | $-28 | $-28 | $-23 | $-15 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,935 | 4,741 | 4,741 | 1,376 |
| Debt Repayment | -70 | -276 | -217 | -109 | -52 |
| Common Stock Issued | N/A | 26 | 26 | 26 | 26 |
| Other Financing Activity | 0 | 5,059 | 0 | 0 | 0 |
| Financing Cash Flow | $-70 | $9,744 | $4,550 | $4,657 | $1,350 |
| Beginning Cash Position | 3,697 | 79 | 79 | 79 | 79 |
| End Cash Position | 2,005 | 3,697 | 261 | 1,765 | 82 |
| Net Cash Flow | $-1,692 | $3,618 | $182 | $1,687 | $3 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,604 | -6,098 | -4,340 | -2,947 | -1,332 |
| Capital Expenditure | -18 | -28 | -28 | -23 | -15 |
| Free Cash Flow | -1,622 | -6,126 | -4,368 | -2,971 | -1,347 |